Our Solution

Introducing the first and only integrated platform for every layer of the human data stack

Organ access Network
hardware icon
Hardware
data stack icon
DATA
software icon
SOFTWARE
Clinical Access Network

Revalia’s platform moves drug development forward faster–by enabling Human Data Trials.

Learn More

Revalia enhances each core pillar of drug development

search icon

Discovery

Core Activities

Target identification and validation
Hit-to-lead screening
Model-based hypothesis testing

With Revalia

Validates targets with real human tissue data
Reduces false positives from non-human systems
safety icon

Safety / Tox

Core Activities

Animal model toxicology studies
In vitro cytotoxicity and dose-range finding
IND-enabling safety assessments

With Revalia

Human organ response insight, pre-IND
Early flagging of human-specific toxicities
microscope icon

PK / Biodistribution

Core Activities

ADME profiling using animal models
Tissue sampling in preclinical species
In silico and in vitro simulation

With Revalia

Tracks compound movement in perfused human tissue
Reveals tissue-specific exposure patterns early
search icon

Efficacy

Core Activities

Disease modeling in animals or organoids
Preclinical endpoint mapping
Biomarker identification

With Revalia

Tests efficacy in real human systems
Confirms mechanism-of-action in target tissues

Introducing Human Data Trials

A new chapter in translational research.

The traditional research pipeline waits too long for human relevance. Human Data Trials offer an earlier window into biology—before patient risk and clinical trial expense.

Medical worker in uniform carrying a cooler box for organ transport
ARTICLE

Honoring the gift: The transformative potential of transplant-declined human organs

American Journal of Transplantation, Volume 23, Issue 2, 165 - 170

vector illustration of human kidney

Bridge the gap between biology and breakthrough

Ready to accelerate your next program?